vs
Side-by-side financial comparison of FTC Solar, Inc. (FTCI) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.
FTC Solar, Inc. is the larger business by last-quarter revenue ($32.9M vs $18.3M, roughly 1.8× ROCKWELL MEDICAL, INC.). ROCKWELL MEDICAL, INC. runs the higher net margin — -3.0% vs -110.7%, a 107.7% gap on every dollar of revenue. On growth, FTC Solar, Inc. posted the faster year-over-year revenue change (148.9% vs -25.6%). ROCKWELL MEDICAL, INC. produced more free cash flow last quarter ($2.2M vs $-8.4M). Over the past eight quarters, FTC Solar, Inc.'s revenue compounded faster (61.6% CAGR vs -10.1%).
FTC Solar, Inc. is a leading global provider of advanced solar tracker systems, associated components, and supporting software for solar projects. It serves utility-scale, commercial, and industrial solar segments across key global markets, helping customers boost energy generation efficiency and lower overall project costs.
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
FTCI vs RMTI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $32.9M | $18.3M |
| Net Profit | $-36.4M | $-554.0K |
| Gross Margin | 14.9% | 21.1% |
| Operating Margin | -17.2% | -2.2% |
| Net Margin | -110.7% | -3.0% |
| Revenue YoY | 148.9% | -25.6% |
| Net Profit YoY | -197.4% | 26.7% |
| EPS (diluted) | $-2.31 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $32.9M | $18.3M | ||
| Q3 25 | $26.0M | $15.9M | ||
| Q2 25 | $20.0M | $16.1M | ||
| Q1 25 | $20.8M | $18.9M | ||
| Q4 24 | $13.2M | $24.7M | ||
| Q3 24 | $10.1M | $28.3M | ||
| Q2 24 | $11.4M | $25.8M | ||
| Q1 24 | $12.6M | $22.7M |
| Q4 25 | $-36.4M | $-554.0K | ||
| Q3 25 | $-23.9M | $-1.8M | ||
| Q2 25 | $-15.4M | $-1.5M | ||
| Q1 25 | $-3.8M | $-1.5M | ||
| Q4 24 | $-12.2M | $-756.0K | ||
| Q3 24 | $-15.4M | $1.7M | ||
| Q2 24 | $-12.2M | $343.0K | ||
| Q1 24 | $-8.8M | $-1.7M |
| Q4 25 | 14.9% | 21.1% | ||
| Q3 25 | 6.1% | 14.3% | ||
| Q2 25 | -19.6% | 15.6% | ||
| Q1 25 | -16.6% | 16.1% | ||
| Q4 24 | -29.1% | 14.7% | ||
| Q3 24 | -42.5% | 22.0% | ||
| Q2 24 | -20.5% | 17.6% | ||
| Q1 24 | -16.7% | 13.5% |
| Q4 25 | -17.2% | -2.2% | ||
| Q3 25 | -29.6% | -9.9% | ||
| Q2 25 | -57.5% | -8.4% | ||
| Q1 25 | -50.8% | -7.2% | ||
| Q4 24 | -101.7% | -2.1% | ||
| Q3 24 | -147.8% | 6.8% | ||
| Q2 24 | -104.3% | 2.0% | ||
| Q1 24 | -99.3% | -5.8% |
| Q4 25 | -110.7% | -3.0% | ||
| Q3 25 | -92.0% | -11.0% | ||
| Q2 25 | -77.2% | -9.3% | ||
| Q1 25 | -18.4% | -8.0% | ||
| Q4 24 | -92.7% | -3.1% | ||
| Q3 24 | -151.5% | 5.9% | ||
| Q2 24 | -107.1% | 1.3% | ||
| Q1 24 | -69.7% | -7.6% |
| Q4 25 | $-2.31 | $-0.01 | ||
| Q3 25 | $-1.61 | $-0.05 | ||
| Q2 25 | $-1.18 | $-0.05 | ||
| Q1 25 | $-0.58 | $-0.04 | ||
| Q4 24 | $-0.95 | $-0.02 | ||
| Q3 24 | $-1.21 | $0.04 | ||
| Q2 24 | $-0.97 | $0.01 | ||
| Q1 24 | $-0.70 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $21.1M | $10.7M |
| Total DebtLower is stronger | $9.9M | — |
| Stockholders' EquityBook value | $-43.0M | $37.0M |
| Total Assets | $111.8M | $57.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $21.1M | $10.7M | ||
| Q3 25 | $24.4M | $13.6M | ||
| Q2 25 | $3.5M | $12.5M | ||
| Q1 25 | $5.9M | $11.4M | ||
| Q4 24 | $11.2M | $15.7M | ||
| Q3 24 | $8.3M | $12.3M | ||
| Q2 24 | $10.8M | $11.9M | ||
| Q1 24 | $14.0M | $6.6M |
| Q4 25 | $9.9M | — | ||
| Q3 25 | $16.6M | — | ||
| Q2 25 | $10.9M | — | ||
| Q1 25 | $10.2M | — | ||
| Q4 24 | $9.5M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $-43.0M | $37.0M | ||
| Q3 25 | $-13.7M | $37.0M | ||
| Q2 25 | $9.0M | $30.4M | ||
| Q1 25 | $15.5M | $31.5M | ||
| Q4 24 | $19.0M | $32.6M | ||
| Q3 24 | $30.4M | $29.1M | ||
| Q2 24 | $44.2M | $23.5M | ||
| Q1 24 | $55.2M | $20.6M |
| Q4 25 | $111.8M | $57.1M | ||
| Q3 25 | $111.5M | $57.5M | ||
| Q2 25 | $83.0M | $52.6M | ||
| Q1 25 | $84.1M | $54.0M | ||
| Q4 24 | $89.9M | $59.2M | ||
| Q3 24 | $91.7M | $57.1M | ||
| Q2 24 | $100.3M | $53.0M | ||
| Q1 24 | $115.0M | $50.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 1.20× | — | ||
| Q1 25 | 0.65× | — | ||
| Q4 24 | 0.50× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-8.0M | $2.3M |
| Free Cash FlowOCF − Capex | $-8.4M | $2.2M |
| FCF MarginFCF / Revenue | -25.7% | 12.0% |
| Capex IntensityCapex / Revenue | 1.3% | 0.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-34.6M | $-1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-8.0M | $2.3M | ||
| Q3 25 | $-14.6M | $-1.3M | ||
| Q2 25 | $-2.3M | $1.8M | ||
| Q1 25 | $-8.5M | $-3.5M | ||
| Q4 24 | $-16.7M | $865.0K | ||
| Q3 24 | $-2.4M | $4.3M | ||
| Q2 24 | $-3.8M | $1.4M | ||
| Q1 24 | $-11.9M | $-2.4M |
| Q4 25 | $-8.4M | $2.2M | ||
| Q3 25 | $-15.1M | $-1.5M | ||
| Q2 25 | $-2.5M | $1.7M | ||
| Q1 25 | $-8.6M | $-3.5M | ||
| Q4 24 | $-17.0M | $470.0K | ||
| Q3 24 | $-2.6M | $4.1M | ||
| Q2 24 | $-4.5M | $1.2M | ||
| Q1 24 | $-12.3M | $-2.5M |
| Q4 25 | -25.7% | 12.0% | ||
| Q3 25 | -57.9% | -9.6% | ||
| Q2 25 | -12.4% | 10.5% | ||
| Q1 25 | -41.2% | -18.8% | ||
| Q4 24 | -128.6% | 1.9% | ||
| Q3 24 | -25.6% | 14.4% | ||
| Q2 24 | -39.2% | 4.5% | ||
| Q1 24 | -97.6% | -11.1% |
| Q4 25 | 1.3% | 0.5% | ||
| Q3 25 | 1.7% | 1.4% | ||
| Q2 25 | 0.9% | 1.0% | ||
| Q1 25 | 0.4% | 0.3% | ||
| Q4 24 | 2.2% | 1.6% | ||
| Q3 24 | 2.2% | 0.7% | ||
| Q2 24 | 6.1% | 1.1% | ||
| Q1 24 | 3.4% | 0.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.57× | ||
| Q2 24 | — | 4.20× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FTCI
| Products | $26.2M | 80% |
| Services | $6.7M | 20% |
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
